In addition, MELK regulates cell cycle progression (40), leading to a worse prognosis in patients with adrenal cortical carcinoma and Wilms tumor (41, 42), and it could be a novel target for cancer therapy (43). Here, MELK is linked to adrenal cortex carcinoma.